Category: Psychiatry · Systemic lupus erythematosus · Depression · Corticosteroids
Does SLE Really Raise the Risk of Depression? Inflammation and the Brain, Steroid Effects on Mood, the Burden of Seeing Many Specialists, and Joint Care with Psychiatry
AI Overview / Quick Answer (BLUF)
Depression is common in SLE: about one in four patients meet criteria on clinical interview. Causes overlap: inflammation signalling to the brain,
high-dose steroids, pain, fatigue and treatment burden. It is treatable. Tell your rheumatologist, get screened, never stop medicines yourself, and seek urgent help for self-harm thoughts.
Reader question: I heard SLE raises the risk of depression. Is that true?
A member of an SLE patient group asked whether it is true that lupus raises the risk of depression. Several members added that they see 3–4 specialists,
take many medicines, have to give up many activities, and feel discouraged and drained, to the point of wondering whether they are depressed or just imagining it.
Short answer: yes, research backs this up, and it is not weakness. Most depression in SLE has several causes at once, not brain inflammation alone.
The good news is that it is treatable, and a long-term cohort found that about half of mood disorder episodes resolved during follow-up.
If poor sleep is part of the picture, see
SLE insomnia and rash flares: safe sleep care
Warning signs that need hospital care now, not the next appointment
Direct answer: thoughts of death, hearing voices, confusion or seizures in someone with SLE can come from severe depression, medicine effects, infection or lupus affecting the brain. All of them need assessment straight away.
Go to the emergency department or call emergency services (1669 in Thailand) now
- Thoughts of death, a plan, or self-harm. Call a crisis line (1323 in Thailand) or emergency services now, and do not stay alone
- Hearing or seeing things others do not, or severe paranoia, especially after starting or raising a steroid dose
- Confusion, not knowing the day or time, or unusual drowsiness that develops over hours to a few days
- Several nights without sleep but not tired, racing speech, unusual spending or risk-taking, which may be steroid-related mania
- Seizure, loss of consciousness, or a severe headache unlike any before
- One-sided weakness, facial droop, slurred speech or sudden vision loss
- High fever with drowsiness, confusion or a stiff neck while on immunosuppressants, which may be an infection
A meta-analysis of 17 studies with 5,174 people with rheumatic diseases, including SLE (Li 2018),
found suicidal ideation in 26%. The authors advise rheumatologists to ask about it routinely, so raising these thoughts with your doctor is normal and safe.
Book a doctor visit within a few days
- Low mood, loss of interest or feeling worthless most days for more than 2 weeks
- Several nights in a row without sleep that affect work or self-care
- Wanting to stop medicines or skip appointments because you feel discouraged or drained
- Relying on alcohol or self-bought sleeping pills to get through each day
1. Does SLE really raise the risk of depression? The research numbers
Direct answer: yes. A meta-analysis of 59 studies with 10,828 patients found major depression in about 24% on clinical interview.
The 30–40% figure often quoted comes from screening questionnaires, which give higher numbers than an actual diagnosis.
Prevalence depends on how it is measured
A meta-analysis of 59 studies (Zhang 2017)
found major depression in 24% by clinical interview, 30% with the HADS questionnaire and 39% with the BDI, and anxiety in 37%.
The authors concluded that rheumatologists should screen for depression and anxiety routinely and refer to mental health professionals when found.
Depression caused by SLE itself exists, but it is not the majority
The American College of Rheumatology defines 19 neuropsychiatric lupus syndromes, and mood disorders are one of them
(ACR 1999).
A meta-analysis (Unterman 2011) found mood disorders in 20.7% of people with SLE.
But an international inception cohort that followed 1,827 patients from diagnosis (Hanly 2015)
found mood disorders in 12.7%, and doctors attributed only 38.3% of episodes to SLE itself. The 10-year cumulative risk was 17.7%.
Mood disorders were not linked to overall disease activity, organ damage or blood autoantibodies, so the authors concluded the causes are multifactorial.
Not weakness, and treatable
In the same study, 72.4% of patients with depression received antidepressants, and 49.2% of mood disorder episodes resolved during follow-up.
People on immunosuppressive drugs had a lower risk, which fits the idea that controlling lupus also helps mood.
SLE is a long-term disease that can be brought into remission, so feeling discouraged now does not mean it will always be this way.
2. How inflammation affects the brain: what we know and what we do not
Direct answer: inflammatory signals in the blood reach the brain by several routes and cause fatigue, low drive and sleep changes that resemble depression.
But in SLE no single model explains everything, and blood antibody tests cannot confirm the cause of depression.
From inflammation to sickness and depression
During inflammation, immune cells release cytokines such as IL-1, IL-6 and TNF-alpha, which signal the brain to produce “sickness behaviour”: tiredness, poor appetite, social withdrawal.
When inflammation persists, as in autoimmune disease, this can develop into depression in vulnerable people
(Dantzer 2008).
Evidence from interferon-alpha treatment
The clearest proof that inflammatory signals can cause depression comes from people with hepatitis C treated with interferon-alpha. A review of 26 studies
(Udina 2012)
found that about one in four (25%) developed major depression within 24 weeks, and those with high IL-6 before treatment were at greater risk.
Many people with SLE have high type I interferon activity, so the biology is plausible, but the link remains indirect.
The blood-brain barrier and antibodies
A review (Schwartz 2019)
concluded that brain-reactive antibodies, cytokines, immune cells, resident microglia and a leakier blood-brain barrier all play a part,
but the mood and thinking symptoms of SLE remain poorly understood and no unifying model explains every case. Saying inflammation “crosses over and destroys serotonin directly” oversimplifies it.
Can a blood test tell whether depression comes from SLE?
Not yet. A meta-analysis of 1,537 patients from 14 research teams (Karassa 2006)
found anti-ribosomal P antibodies had a sensitivity of only 27% and specificity of 80% for psychosis or mood disorder, so their diagnostic value is limited.
EULAR guidance says psychiatric symptoms in SLE should first be assessed and treated as in anyone else, and only then attributed to SLE
(Bertsias 2010).
Where do your low mood, sleep and exhaustion sit right now, and is it time to get help?
Analyse the severity and get personalised guidance from our Advisory team. The mental-health urgency assessment grades low mood, anxiety, sleep
and impact on daily life into watch, book a visit, or do not wait. It is not a diagnosis.
If you have self-harm thoughts, hear voices or feel confused, call 1323 or emergency services now without waiting for a score.
3. Steroids, mood and sleep
Direct answer: steroids can cause insomnia, mood swings, depression or abnormal elation, and the risk rises with dose.
But do not stop or lower steroids on your own; doctors can taper them safely with the help of other disease-control medicines.
Risk rises with dose
A drug surveillance report on people taking prednisone (Boston 1972)
found psychiatric reactions in 1.3% at up to 40 mg/day, 4.6% at 41–80 mg/day and 18.4% above 80 mg/day.
Bar length = percentage × 4, from the Boston Collaborative Drug Surveillance Program 1972
Data from more than 300,000 patients
A UK primary care database study of 372,696 people given oral steroids (Fardet 2012),
compared with people with the same conditions who were not, found 1.83 times the risk of depression, 4.35 times mania, 5.14 times delirium or confusion, and 6.89 times suicide or attempted suicide.
People with a past psychiatric history and those on higher doses were at greater risk. The authors advise patients and families to learn these signs so they can tell the doctor early.
In people with SLE
A prospective study of 92 people with SLE (Chau & Mok 2003)
found steroid-induced psychosis in 5%, more often in those with low blood albumin, which is common with lupus kidney disease.
This helps doctors watch higher-risk patients closely.
Current guidance: as little and as short as needed
The EULAR 2023 recommendations (Fanouriakis 2024)
use steroids as “bridging therapy” during flares and advise lowering them to 5 mg/day or less for maintenance, or stopping when possible,
with hydroxychloroquine for all patients and early immunosuppressants such as methotrexate, azathioprine, mycophenolate, or the biologics belimumab and anifrolumab to help reduce steroids.
If you suspect your medicine is changing your mood, tell your doctor. Doctors often move the dose to the morning to protect sleep and plan a safe taper.
4. Exhausted by many specialists and many medicines
Direct answer: treatment burden, such as appointments in several departments, many medicines and daily-life limits, is a real source of exhaustion.
Some people call it doctor fatigue. It is not a medical diagnosis, but it is a problem that better organisation of visits and medicines can ease.
Depression, many medicines and missed doses are linked
A systematic review of 11 studies (Mehat 2017)
found that 43–75% of people with SLE did not take medicines as prescribed, and up to 33% stopped therapy within 5 years. Linked factors included depression,
taking many medicines, rural residence and education level. Treating depression therefore also helps people take their lupus medicines more consistently.
Ways to reduce the burden of visits and medicines
- Ask a nurse or appointment coordinator to combine visits, such as rheumatology, eye and bone clinics, on one day when possible
- Keep one medicine notebook or list with generic names, doses, times and anything you buy yourself, and show the same list to every clinic
- Ask your doctor which medicines can be stopped or combined to reduce the number of doses each day
- Ask whether some follow-ups can be done by telemedicine or with blood tests near home
- Tell your rheumatologist plainly that you feel discouraged or tired of treatment, because this helps plan your care
- Bring a family member or friend on multi-clinic days to take notes and share the load
5. Caring for body and mind together: rheumatologist, psychiatrist and psychologist
Direct answer: the main doctor for SLE is a rheumatologist, who can screen for depression with a short questionnaire and refer to a psychiatrist or clinical psychologist.
Collaborative care, cognitive behavioural therapy and exercise all have supporting evidence.
Screening with the PHQ-9
The PHQ-9 is a 9-item questionnaire that takes a few minutes. A study of 6,000 patients (Kroenke 2001)
found that a score of 10 or more had 88% sensitivity and 88% specificity for major depression. The score informs your doctor’s assessment; it is not a self-diagnosis.
Collaborative care
A Cochrane review of 79 trials with 24,308 participants (Archer 2012)
found that care in which a coordinator, the main doctor and a mental health professional work together improved depression more than usual care (SMD −0.34 in the short term)
and raised patient satisfaction. The same principle can be applied between rheumatology and psychiatry clinics.
Cognitive behavioural therapy in lupus
A randomized trial in 45 people with lupus and high stress (Navarrete-Navarrete 2010)
found that 10 weekly CBT sessions reduced depression, anxiety and stress, and quality of life improved over 15 months of follow-up, although immune blood markers did not change.
Moderate exercise
A meta-analysis of 11 studies with 469 patients (O’Dwyer 2017)
found exercise was safe, did not worsen disease activity, and reduced depression and fatigue. Start with brisk walking or easy cycling for 10–20 minutes a day while the disease is quiet.
Antidepressants in SLE: usable, but your whole medicine list matters
SSRIs such as sertraline, escitalopram and fluoxetine can be used in SLE, but antidepressants can interact with other medicines, so your doctor needs your full medicine list.
For example, SSRIs taken with NSAID painkillers raised the risk of upper gastrointestinal bleeding 4.25-fold (1.66-fold for SSRIs alone)
(Anglin 2014),
and hydroxychloroquine is associated with a longer QTc interval (OR 1.57) (Nikolic 2024),
which some antidepressants can also lengthen. Your doctor may check an ECG before or during treatment. Antidepressants take 2–6 weeks to work. Do not stop prescribed medicine on your own.
Table: depression from chronic illness, depression attributed to SLE, and steroid-related mood change
In real life the causes often overlap and telling them apart needs a doctor’s assessment. This table helps you understand them and describe symptoms more clearly.
| Type | Proposed mechanism | Main symptoms | Typical timing | Management |
|---|---|---|---|---|
| Depression from chronic illness | Pain, fatigue, treatment burden, loss of roles | Discouragement, low motivation, feeling like a burden | Any time, often tied to life events | CBT, antidepressants, fewer visits and medicines, support groups |
| Depression attributed to SLE itself | Cytokines, interferon, antibodies, a leakier blood-brain barrier | Often with other neurological symptoms such as memory or concentration problems | Often near disease onset or a flare | Standard depression treatment plus disease control with immunosuppressants |
| Steroid-related mood change | The drug binds receptors in the hippocampus and amygdala and disturbs the stress hormone axis | Insomnia, irritability, elation or low mood, sometimes hearing voices | Days to weeks after starting or raising the dose | Tell the doctor, adjust dose or timing, never stop on your own |
A multi-clinic care plan for people with SLE
Adapt it to your hospital’s system and use it as a checklist with your doctors and nurses.
| Care area | What to do | Effect on body and mind | Tips |
|---|---|---|---|
| Mood screening | PHQ-9 and a question about self-harm thoughts at every visit | Finds depression early, before it becomes severe | Answer honestly; it will not be seen as weakness |
| Disease control | Hydroxychloroquine, immunosuppressants, steroids lowered to 5 mg/day or less | Less inflammation and fewer steroid effects on mood | Take medicines as scheduled; never lower steroids yourself |
| Depression treatment | CBT with a psychologist and/or antidepressants from a psychiatrist | Better mood, sleep and quality of life | Bring your full medicine list to the psychiatrist |
| Fewer visits | Combined appointment days, one medicine notebook, telemedicine when suitable | Less exhaustion, fewer missed visits and doses | Ask the nurse coordinator from the first visit |
| Physical recovery | Moderate exercise, regular sleep, sun protection | Less fatigue and fewer depressive symptoms | Start small while the disease is quiet; stop with joint pain or fever |
| Safety monitoring | Check drug interactions, ECG when needed | Fewer gastrointestinal bleeds and heart rhythm problems | Report every painkiller or herbal product you buy yourself |
Table: comparing options for depression in SLE
Drug classes and generic names only. The choice depends on assessment by your rheumatologist, psychiatrist and other conditions.
| Option | Suits | Evidence | Cautions |
|---|---|---|---|
| SSRI antidepressants (sertraline, escitalopram, fluoxetine) | Moderate to severe depression, or depression with anxiety | 72.4% of people with depression in SLE received antidepressants in long-term follow-up | More bleeding with NSAIDs; some lengthen QTc; never stop on your own |
| Other antidepressants (mirtazapine) | Depression with insomnia or poor appetite | Used per general depression guidance; no SLE-specific trials | Drowsiness and weight gain, which overlap with steroid effects |
| Cognitive behavioural therapy (CBT) | Depression, stress or worry about the disease at any level | Reduced depression and stress in 45 people with lupus, lasting 15 months | Needs a clinical psychologist and several weeks |
| Collaborative care between clinics | People who see many specialists and take many medicines | 79 trials, 24,308 people: depression improved more than usual care | Depends on the hospital system; you may need to ask for it |
| Moderate exercise | People with fatigue whose disease is quiet | 11 studies, 469 people: safe, less depression and fatigue | Avoid during fever or joint flares; mind the sun |
| Adjusting lupus medicines (hydroxychloroquine, azathioprine, mycophenolate, methotrexate, belimumab, anifrolumab) | People still on high-dose steroids or with active disease | EULAR 2023 advises steroids at 5 mg/day or less; immunosuppressants linked to lower mood disorder risk | Adjusted by the rheumatologist; watch for infection |
| Patient support groups | People who feel isolated | Emotional support; SLE-specific evidence is still limited | Not a substitute for treatment; be wary of advice to stop medicines |
Common beliefs versus the evidence
Everyone with SLE will become depressed
No. About one in four has major depression on clinical interview, which is higher than the general population, but most do not, and those who do can improve.
Depression in SLE is all caused by brain inflammation
Most depression in SLE has several causes at once, not brain inflammation alone. In the 1,827-patient cohort, doctors attributed 38.3% of episodes to SLE itself.
Inflammation crosses over and destroys serotonin directly
That oversimplifies it. There are several pathways from inflammation to depression, mostly shown in animal studies and in people given interferon as a drug. In SLE no single model explains it yet.
Antidepressants do not interact with lupus medicines
Antidepressants can interact with other medicines, so your doctor needs your full medicine list, especially NSAID painkillers, blood thinners and drugs that affect heart rhythm.
If steroids make me low, I can stop them myself
Do not stop or lower steroids on your own. Stopping suddenly can leave the adrenal glands unable to keep up, drop blood pressure and trigger a flare. Tell your doctor so a taper can be planned.
An antibody blood test can show depression comes from SLE
Blood antibody tests cannot confirm the cause of depression. Anti-ribosomal P has a sensitivity of only 27%.
SLE cannot be treated and life will only get worse
SLE is a long-term disease that can be brought into remission. Today’s treatment target is remission with little or no steroid, and about half of mood disorder episodes resolved during follow-up.
Frequently asked questions (FAQ)
Are people with SLE really more likely to become depressed?
Yes. A meta-analysis of 59 studies with 10,828 patients found major depression in 24% on clinical interview and 30–39% on screening questionnaires, higher than in the general population. It is not weakness, and it is treatable.
How can inflammation in SLE cause depression?
Cytokines and interferon in the blood signal the brain by several routes, causing fatigue and low drive that can develop into depression. About one in four people given interferon-alpha as a drug develop depression, but in SLE no single model explains it and most depression has several causes at once.
Can steroids cause mood swings or insomnia?
Yes, and the risk rises with dose. Psychiatric reactions occurred in 1.3% at up to 40 mg/day of prednisone and 18.4% above 80 mg/day. A study of 372,696 people found 1.83 times the risk of depression and 4.35 times mania. Doctors often move the dose to the morning to protect sleep.
If I think steroids are making me depressed, should I lower the dose myself?
Do not stop or lower steroids on your own, because stopping suddenly can leave the adrenal glands unable to keep up and trigger a flare. Tell your rheumatologist. EULAR 2023 uses immunosuppressants or biologics to bring steroids down to 5 mg/day or less, or stop them when possible.
Can people with SLE take antidepressants?
Yes. SSRIs such as sertraline and escitalopram are widely used, but antidepressants can interact with other medicines, so your doctor needs your full medicine list. SSRIs with NSAIDs raise gastrointestinal bleeding 4.25-fold, and some combined with hydroxychloroquine may lengthen QTc. Do not stop prescribed medicine on your own.
I am worn out by visiting many hospital departments. Is there a way to ease the load?
Yes. Ask a nurse to combine appointment days, use one medicine notebook, ask whether some follow-ups can be done by telemedicine, and tell your doctor you are tired of treatment. Depression and many medicines are drivers of nonadherence, seen in 43–75%, so easing the load also helps control lupus.
Can a blood test show whether depression comes from SLE?
Not yet. Blood antibody tests cannot confirm the cause of depression. Anti-ribosomal P antibodies have 27% sensitivity and 80% specificity, so doctors assess and treat depression as in anyone else first, then consider whether SLE is involved.
Which symptoms need hospital care straight away?
Thoughts of death or self-harm, hearing voices or severe paranoia, confusion that develops over hours to days, several nights without sleep but not tired, seizures, one-sided weakness, or high fever with drowsiness while on immunosuppressants. Call emergency services or a crisis line (1669 or 1323 in Thailand) now.
Scientific mechanism
Inflammatory signals to the brain: blood cytokines reach the brain through the vagus nerve, areas where the blood-brain barrier is thin, and blood-vessel cells that relay the signal.
This activates microglia, and the enzyme IDO shifts tryptophan towards kynurenine, leaving less tryptophan to make serotonin and producing metabolites that act on neurons.
Most of this comes from animal studies and people given cytokines as drugs
(Dantzer 2008,
Udina 2012).
Specific to SLE: high type I interferon activity, neuron-reactive antibodies and a leakier blood-brain barrier may act together,
but there is no single model, and mood disorder risk is not linked to antibody levels or overall disease activity
(Schwartz 2019,
Hanly 2015).
Steroids and the brain: steroids bind glucocorticoid and mineralocorticoid receptors that are dense in the hippocampus and amygdala,
and suppress the hypothalamic-pituitary-adrenal axis, so higher doses change sleep, mood and perception more
(Fardet 2012).
Written and reviewed by Asst. Prof. Dr. Norawit Raatpiboon
Academic references (E-E-A-T)
- Zhang L et al. Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry 2017 (PMID 28196529)
- Hanly JG et al. Mood disorders in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Rheumatol 2015 (PMID 25778456)
- Unterman A et al. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011 (PMID 20965549)
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999 (PMID 10211873)
- Karassa FB et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006 (PMID 16385548)
- Dantzer R et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008 (PMID 18073775)
- Udina M et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 2012 (PMID 22967776)
- Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol 2019 (PMID 30659245)
- Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972 (PMID 5053810)
- Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 2012 (PMID 22764363)
- Chau SY, Mok CC. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 2003 (PMID 12847167)
- Fanouriakis A et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024 (PMID 37827694)
- Bertsias GK et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations. Ann Rheum Dis 2010 (PMID 20724309)
- Mehat P et al. Medication nonadherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res 2017 (PMID 28086003)
- Li Z et al. The prevalence of suicidal ideation and suicide attempt in patients with rheumatic diseases: a systematic review and meta-analysis. Psychol Health Med 2018 (PMID 29882419)
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001 (PMID 11556941)
- Archer J et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev 2012 (PMID 23076925)
- Navarrete-Navarrete N et al. Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. Psychother Psychosom 2010 (PMID 20090397)
- O’Dwyer T, Durcan L, Wilson F. Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Semin Arthritis Rheum 2017 (PMID 28477898)
- Anglin R et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use. Am J Gastroenterol 2014 (PMID 24777151)
- Nikolic RPA et al. Hydroxychloroquine and chloroquine-induced cardiac arrhythmias and sudden cardiac death in patients with systemic autoimmune rheumatic diseases. J Cardiovasc Pharmacol 2024 (PMID 38922589)
Medical disclaimer
This article gives general information about depression in systemic lupus erythematosus. It is not a diagnosis, prescription or personal treatment plan, and it does not replace assessment by your rheumatologist, psychiatrist or clinical psychologist.
Medicines are named by class or generic name for education only. Do not start, stop or change any medicine on your own, especially steroids.
If you have self-harm thoughts, hear voices, feel confused or have a seizure, call emergency services or a crisis line (1669 or 1323 in Thailand) now.